Toronto – July 16 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to welcome Agescan International Inc. (Agescan), bringing expertise in medical radiation shielding and strengthening the CNIC’s commitment to innovation and safety in the isotope industry.
With customers around the world, Canadian-based Agescan is a rapidly-growing source of tungsten alloy and related products that lead to reduced risk, particularly in areas like nuclear medicine where precision and safety are paramount. Tungsten alloys are dense and excellent at attenuating ionising radiation, which makes them effective for a variety of shielding applications. In the global nuclear medicine industry, Agescan’s advanced tungsten products ensure effective radiation shielding, protecting both medical professionals and patients.
Agescan’s tungsten shielding parts also play a major role in helping with the disposal of radioactive waste by contributing to safer, more efficient handling and containment of these materials.
“The CNIC welcomes Agescan’s global expertise in safe shielding, which aligns with our mission to advance radiation safety and innovation in Canada’s nuclear medicine industry,” said James Scongack, Chair of the CNIC. “As demand for medical isotopes continues to rise, this collaboration will enhance the development of cutting-edge shielding solutions and partnerships that address critical challenges in radiation safety for the Canadian healthcare system.”
Through its involvement with the CNIC, Agescan will utilize its proven track record in producing high-quality tungsten products to support projects across the supply chain and promote excellence, innovation, and safety within the Canadian medical isotope industry.
To learn more about Agescan please visit https://www.agescantungsten.com/
About the Canadian Nuclear Isotope Council
The Canadian Nuclear Isotope Council (CNIC) is an independent, not-for-profit advocacy and member services organization. The CNIC supports over 85 members from across science, academia, healthcare, and nuclear-sector organizations dedicated to maintaining Canada’s position as a global leader in the production of life-saving isotopes. The CNIC raises awareness and advocates for long-term policies that support health-care innovation and will save countless lives for decades to come.
To learn more about the CNIC, visit www.CanadianIsotopes.ca and follow us on Facebook, Twitter, and LinkedIn.
For more information, please contact:
Melody Greaves
Manager, Strategic Relations
Canadian Nuclear Isotope Council
melody.greaves@canadianisotopes.ca